Bill M, Papaioannou D, Karunasiri M, Kohlschmidt J, Walker AE, Brannan Z, Mrózek K,
LaRocco A, Volinia S, Bloomfield CD, Garzon R, Dorrance AM. Expression and functional
relevance of long non-coding RNAs in acute myeloid leukemia stem cells. Leukemia
Mrózek K, Eisfeld AK, Kohlschmidt J, Carroll AJ, Walker CJ, Blachly JS, Bill M,
Papaioannou D, Wang ES, Uy GL, Kolitz JE, Powell BL, Stone RM, Byrd JC, Bloomfield
CD. Complex karyotype in acute myeloid leukemia: typical and atypical subtypes differ
molecularly and clinically. Leukemia
Papaioannou D, Petri A, Dovey OM, Terreri S, Wang E, Collins FA, Woodward LA,
Nicolet D, Kumchala P, Pepe F, Marius Bill M, Karunasiri M, Gardner M, Mrózek K,Zitzer
NC, Camilotto V., Cooper JL, Cai X, Rong-Mullins X, Kohlschmidt J, Archer KJ, Freitas
MA, Zheng Y, Lee R, Aifantis I, Vassiliou G., Singh G., Kauppinen S, Bloomfield CD,
Dorrance AM, Garzon R. The Long Non-Coding RNA HOXB-AS3 Regulates Ribosomal
RNA Transcription in NPM1-Mutated Acute Myeloid Leukemia. Nature Communications
Papaioannou D, Nicolet D, Hatice G Ozer, Mrózek K, Volinia S, Fadda P, Carroll AJ,
Kohlschmidt J, Kolitz JE, Wang ES, Stone RM, Byrd JC, Garzon R, Bloomfield CD.
Prognostic and Biologic Relevance of Clinically Applicable Long Non-Coding RNA
Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia.
Molecular Cancer Therapeutics
Vasu S, Kohlschmidt J, Mrózek K, Eisfeld AK, Nicolet D, Sterling LJ, Becker H, Metzeler
KH, Papaioannou D, Powell BL, Kolitz JE, Moore JO, Baer MR, Roboz GJ, Stone RM,
Byrd JC, Carroll AJ, Bloomfield CD. Ten-year outcome of patients with acute myeloid
leukemia not treated with allogeneic transplantation in first complete remission. Blood
Advances 2018 2:1645-1650
- Papaioannou D, Nicolet D, Volinia S, Mrózek K, Yan P, Bundschuh R, Carroll AJ,
Kohlschmidt J, Blum W, Powell BL, Uy GL, Kolitzg JE, Wang ES, Eisfeld AK, Lucas DM,
Shelley O, Caligiuri MA, Stone RM, Byrd JC, Garzon R, Bloomfield CD. Prognostic and
biologic significance of long non-coding RNA profiling in younger adult patients with
cytogenetically normal acute myeloid leukemia. Haematologica. 2017 Aug;102(8):1391-
1400
- Papaioannou D, Shen C, Nicolet D, McNeil B, Karunasiri M, Matthew Burke, Gulcin
Ozer H, Yilmaz S, Behbehani G, Marcucci G, Powell B, Kolitz J, Carter T, Wang E, Mrozek
K, Caligiuri M, Bloomfield CD, Garzon R, Dorrance AD. Expression, Prognosis and
Mechanistic Insights of EGFL7 in Acute Myeloid Leukemia (AML) Proc Natl Acad Sci U
S A. 2017;114(23):E4641-E4647
- Leoncini PP, Bertaina A, Papaioannou D, Flotho C, Masetti R, Bresolin S, Menna G,
Santoro N, Zecca M, Basso G, Nigita G, Veneziano D, Pagotto S, D’Ovidio K, Rota R,
Dorrance AM, Croce CM, Niemeyer CM, Locatelli F, Garzon R. MicroRNA fingerprints
in Juvenile Myelomonocytic Leukemia (JMML) identified miR-150-5p as a tumor
suppressor and potential target for treatment. Oncotarget. 2016;(7):55395-55408
- Lai TH, Ewald B, Zecevic A, Liu C, Sulda M, Papaioannou D, Garzon R, Blachly JS,
Plunkett W, Sampath D. HDAC inhibition induces microRNA-182 which targets Rad51
and impairs HR repair to sensitize cells to sapacitabine in acute myelogenous leukemia.
Clin Cancer Res. 2016;22(14):3537-3549
- Papaioannou D, Strothmeyer AM, Dühren-von Minden M, Keppler-Hafkemeyer A,
Zirlik K, Mikesch K, van Bergen CA, Navarrete MA, Veelken H. Evidence for idiotypedirected immunosurveillance is restricted to follicular lymphoma and attributable to
somatic hypermutation. Haematologica. 2015;100(4):e143-e146.
- Garzon R, Volinia S, Papaioannou D, Nicolet D, Kohlschmidt J, Yan PS, Mrózek K,
Bucci D, Carroll AJ, Baer MR, Wetzler M, Carter TH, Powell BL, Kolitz JE, Moore JO,
Eisfeld AK, Blachly JS, Blum W, Caligiuri MA, Stone RM, Marcucci G, Croce CM, Byrd
JC, Bloomfield CD. Expression and prognostic impact of lncRNAs in acute myeloid
leukemia. Proc Natl Acad Sci U S A. 2014;111(52):18679-18684.
- Strothmeyer AM, Papaioannou D, Navarrete M, Zirlik K, Mikesch K, Veelken H.
Comparative analysis of predicted HLA binding of the immunoglobulin idiotype
sequences indicates T cell- mediated immunosurveillance in follicular lymphoma. Blood.
2010; 116(10):1734-1736